2-(5-(4-carbamimidoylphenyl)furan-2-yl)benzo[d]oxazole-5-carboximidamide

ID: ALA1650566

PubChem CID: 10132304

Max Phase: Preclinical

Molecular Formula: C19H15N5O2

Molecular Weight: 345.36

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Synonyms: DB828 | CHEMBL1650566|SCHEMBL14519311|DB828

Canonical SMILES:  N=C(N)c1ccc(-c2ccc(-c3nc4cc(C(=N)N)ccc4o3)o2)cc1

Standard InChI:  InChI=1S/C19H15N5O2/c20-17(21)11-3-1-10(2-4-11)14-7-8-16(25-14)19-24-13-9-12(18(22)23)5-6-15(13)26-19/h1-9H,(H3,20,21)(H3,22,23)

Standard InChI Key:  QGSDZVBDALDXMK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    7.3465  -21.3148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3452  -22.1429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0587  -22.5562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7785  -22.1425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7754  -21.3107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0567  -20.9016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6296  -22.5547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9152  -22.1409    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6284  -23.3804    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4879  -20.8949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1566  -21.3821    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8261  -20.8990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5736  -20.1129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7479  -20.1104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5358  -21.3102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6247  -22.1255    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2900  -20.9773    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8380  -21.5876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4249  -22.2932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8295  -23.0016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6468  -23.0055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0580  -22.2952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6511  -21.5897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0576  -23.7217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6427  -24.4355    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8832  -23.7242    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 10  2  0
  2  7  1  0
 12 15  1  0
 15 16  2  0
  3  4  2  0
  7  8  2  0
 16 19  1  0
 18 17  1  0
 17 15  1  0
  7  9  1  0
 18 19  2  0
  4  5  1  0
 19 20  1  0
  5 10  1  0
 20 21  2  0
 10 11  1  0
 21 22  1  0
  2  3  1  0
 22 23  2  0
 23 18  1  0
  5  6  2  0
 21 24  1  0
  6  1  1  0
 24 25  1  0
  1  2  2  0
 24 26  2  0
M  END

Associated Targets(Human)

HOXA9 DNA binding site (122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trypanosoma evansi (198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 345.36Molecular Weight (Monoisotopic): 345.1226AlogP: 3.32#Rotatable Bonds: 4
Polar Surface Area: 138.91Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 11.22CX LogP: 1.81CX LogD: -2.94
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.33Np Likeness Score: -0.77

References

1. Gillingwater K, Kumar A, Anbazhagan M, Boykin DW, Tidwell RR, Brun R..  (2009)  In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model.,  53  (12): [PMID:19786604] [10.1128/aac.00422-09]
2. Depauw S, Lambert M, Jambon S, Paul A, Peixoto P, Nhili R, Marongiu L, Figeac M, Dassi C, Paul-Constant C, Billoré B, Kumar A, Farahat AA, Ismail MA, Mineva E, Sweat DP, Stephens CE, Boykin DW, Wilson WD, David-Cordonnier MH..  (2019)  Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model.,  62  (3.0): [PMID:30645099] [10.1021/acs.jmedchem.8b01448]

Source